LORTON, Va., April 13 /PRNewswire/ -- Nano Interface Technology, Inc.
(NITI) announces evaluation of its product in collaboration with the Naval
Research Laboratory (NRL) and the Virginia Commonwealth University (VCU).
These leading institutions involved in nanotechnology research are working
with the Nano Interface Technology to examine a variety of
nano-biomaterials for coating of orthopedic/dental implants and other
NITI has signed a Corporate Research and Development Agreement (CRADA)
with NRL related to coatings for orthopedic implants. The collaboration
with VCU will address innovative dental applications.
"We are very pleased to sign a CRADA with the NRL because NRL is a
pioneer research organization in nanotechnology and has contributed very
significantly in the development of several nanotechnology-based products.
NITI continues to develop products using its proprietary platform
technology; its products are examined through relationships with top
government and academic institutions. The new products assessment
relationships are solidifying our leadership in commercializing ultra-pure
nano-biomaterials for orthopedic and dental applications," stated Dr. C. P.
Singh, President & CEO at Nano Interface Technology. "In the nanotechnology
arena, only those companies which have slow and steady growth will win the
race," he added.
"The collaboration with Nano Interface Technology will accelerate
development of better products for orthopedic and dental applications,"
stated Dr. Peter C. Moon, Director of Dental Biomaterials Laboratory at the
Virginia Commonwealth University.
About Nano Interface Technology, Inc.
NITI is launching a portfolio of products based on ultra-pure nano-
biomaterials for medical devices such as hip, knee and dental implants.
These nano-biomaterials based devices are scalable and use ultra-pure nano-
biomaterials developed using proprietary platform technology. These nano-
biomaterials can be applied to a broad range of medical applications where
the purity, strength and perfect biocompatibility of biomaterials are
paramount for the success rate of such products.
SOURCE Nano Interface Technology, Inc.